PROVIDER PROFILE · NPI 1982679429
Victor Salas
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
100
Beneficiaries
—
Total drug cost
$594
Distinct drugs
7
Brand share
19.0%
Top prescribed drugs
Hydrocodone/Acetaminophen19 claims
Cefdinir17 claims
Cephalexin13 claims
Azithromycin13 claims
Nabumetone13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Victor Salas's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Weland Clinical Laboratories, P.C. Clinical Laboratory · Cedar Rapids, IA | 30 | 68 |
| STATE UNIVERSITY OF IOWA | 15 | 34 |
| ST LUKE'S METHODIST HOSPITAL | 14 | 28 |
| Sara Hubbell Nurse Practitioner · Cedar Rapids, IA | 13 | 29 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE